Literature DB >> 8555561

Mechanical circulatory support and heart transplantation. Pre-operative status and outcome.

A Schiessler1, N Friedel, Y Weng, U Heinz, M Hummel, R Hetzer.   

Abstract

Between July 1988 and December 1993, 118 patients waiting for heart transplantation underwent mechanical circulatory support by an extracorporeal, pneumatically driven assist device (the Berlin Heart System) to maintain a sufficient circulation and to restore impaired organ function (109 patients requiring a biventricular assist device [BVAD], 9 patients requiring a left ventricular assist device [LVAD]). Before implantation, all patients were in severe cardiogenic shock, despite maximum inotropic support; all had end organ failure. The aim of a retrospective study in 70 patients (for whom pre-operative parameters were available) was to identify patients who would permit from this procedure and could undergo successful transplantation. After a mean bridging time of 34.8 days, 75 (63.5%) patients underwent transplant, and 52 (44.1%) were discharged. Pre-operative coagulation parameters (fibrinogen, antithrombin III, platelet count, and kinetics) were correlated to post-operative blood loss and outcome. Patients who had no or mild coagulation disorders because of a shorter phase of low cardiac output before implantation of the assist device proved to gain faster restitution of organ function and most underwent transplantation. As a result of these observations, implantation of an assist device before shock-induced coagulopathy could occur allowed a greater number of patients to undergo successful bridging and be discharged after heart transplantation.

Entities:  

Mesh:

Year:  1994        PMID: 8555561     DOI: 10.1097/00002480-199407000-00045

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  1 in total

1.  Thoratec paracorporeal biventricular assist device therapy: the Freiburg experience.

Authors:  Kerstin Brehm; Claudia Heilmann; Matthias Siepe; Christoph Benk; Friedhelm Beyersdorf; Christian Schlensak
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.